Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00967213Phase 3Completed
Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Dept. of ophthalmology, KyungHee Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaorong Li, professor

Tianjin Medical University Eye Hospital

Moderately Similar
5 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Xiaodong Sun, M.D.

Shanghai General Hospital, Shanghai Jiao Tong University

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Jamie Dananberg, MD

UNITY Biotechnology

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Se Joon Woo

Seoul National University Bundang Hospital, South Korea

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Mingwei Zhao, PhD

Peking University People's Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Federico Grossi, MD PhD

Apellis Pharmaceuticals, Inc.

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Martin Wax, MD

PanOptica, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Michael Elman, MD

Michael Elman, M.D. 9114 Philadelphia Rd #310 Baltimore, Maryland 21237

Moderately Similar
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Jeffrey Heier, MD

Ophthalmic Consultants of Boston

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Sharon Klier, MD, MPH

Unity Biotechnology, Inc.

Moderately Similar
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00967213Phase 3PrincipalInvestigator

Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
Completed

All 1 trials loaded